Graft-vs-Host Disease (GvHD) Models
GvHD Induction using Immuno-Deficient Mouse Models engrafted with human PBMCs
PBMC from healthy donors are injected in NCG mice – Monitoring of the survival curve and Global clinical score
Example using Cyclosporine A treatment in n=12 mice per group (8-week old), 3 PBMCs donors randomised in the study
- Cyclosporin-A treatment significantly reduced the mortality and the global clinical score as compared to the vehicle group (PBS)
- Circulating CD8+ T lymphocytes are decreased by Cyclosporin-A treatment
If you are interested in NASH, fatty liver disease (NAFLD), liver fibrosis or lung fibrosis, do not hesitate to contact us.